Drugs / cBMA
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT02863926 | Jan 2017 → Jul 2018 | limb ischemia, peripheral arterial disease | Michael Murphy | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | cBMA | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02863926 ↗ |